| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Short Communication |
1 Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan
2 Department of Gastroenterology, St Luke's Medical Center, Quezon, The Philippines
3 Tohoku University School of Health Sciences and Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation, Sendai, Japan
4 Department of Internal Medicine, Mizusawa General Hospital, Iwate, Japan
Correspondence
Hirofumi Niitsuma
hbvdna{at}ma.mni.ne.jp
 |
ABSTRACT |
|---|
 TOP ABSTRACT MAIN TEXTREFERENCES |
|---|
The GenBank/EMBL/DDBJ accession numbers for the complete-genome sequences described in this paper are AB219426 [GenBank] –AB219430 [GenBank] .
A table showing a comparison of nucleotide similarities in the precore and core gene of the present five isolates from the Philippines and representative HBV/B isolates from four other subgenotypes, B1–B4, with isolates from HBV/C and B1 is available in JGV Online.
|
MAIN TEXT |
|---|
|
TOPABSTRACTMAIN TEXTREFERENCES |
|---|
). The subtypes of HBV have been determined serologically by the antigenic determinants of the HBV surface antigen (HBsAg), common determinant a and two mutually exclusive determinant pairs, d/y and w/r. As subtype, i.e. serotype, is mainly defined by a limited number of amino acids, one point mutation in the HBsAg gene could change the serotype in a patient (Okamoto et al., 1987). Therefore, serotyping has its limitations for the classification of HBV.
In 1988, Okamoto and colleagues proposed classifying HBV according to genotype, the genetic classification of HBV based on the comparison of entire genomes, and found an intergroup divergence of 8 % or more (Okamoto et al., 1988). As the classification of HBV by genotype is based on full genome sequences, it is more reliable.
Eight different genotypes of HBV, named A–H, have been determined to date (Okamoto et al., 1988; Norder et al., 1992; Stuyver et al., 2000; Arauz-Ruiz et al., 2002). The distribution of genotypes throughout the world has been confirmed, with genotype A being predominant in North Africa and north-western Europe, genotype B in South-East Asia, genotype C in North-East Asia, genotype D in northern Europe and the Middle East, genotype E in Africa, genotype F in South America and genotype G in France, Germany, the USA and Mexico (Magnius & Norder, 1995; Lindh et al., 1997; Stuyver et al., 2000). Genotype H was recently reported to be detected in South and Central America (Arauz-Ruiz et al., 2002).
There have been some reports that clinical outcomes vary with HBV genotypes. For example, for genotypes B and C, which are characteristic of Asia, genotype B has been found to cause HBe seroconversion more frequently than genotype C, and those infected with HBV/B appear to have better prognoses (Sunitha et al., 2000).
The division of HBV/B into four subgenotypes, B1, B2, B3 and B4, based on the sequence divergence, has recently been reported (Norder et al., 2004). Ba (B2, B3 and B4) has recombined with genotype C and has a higher prevalence of HBe antigen, so it manifests a more severe clinical course than Bj (B1) (Sugauchi et al., 2002). Thus, HBV needs to be examined with regards not only to its genotype, but also to its subgenotypes.
The Philippines are located in South-East Asia, where HBV is hyperendemic. It is reported that about 10 % of the population of the Philippines are HBV carriers, and that chronic HBV infection is a major health problem (Lingao et al., 1989), although to our knowledge, few data on HBV genotype distribution in the country are available. We obtained sera containing HBV isolates from carriers in the Philippines and investigated their features.
The serum samples were provided by St Luke's Medical Center, Quezon City, the Philippines. Quezon City has a population of about 2 100 000 and is the biggest of the cities in the Metro Manila, the capital of the Republic of the Philippines. The patients were HBV carriers being followed at St Luke's. All patients were negative for antibody to Hepatitis C virus and human immunodeficiency virus and were not intravenous drug abusers. The five patients were a 30-year-old male, a 48-year-old female, a 21-year-old male, a 60-year-old male and a 54-year-old male. They were all positive for HBe antigen and negative for anti-HBe. We explained the purpose of this study and collected serum samples with informed consent.
For amplification of HBV DNA by PCR, nucleic acids were extracted from 200 µl serum as described previously (Niitsuma et al., 1995). For analysis of the entire nucleotide sequence, we divided the entire HBV genome into six overlapping segments and amplified each segment. Extracted DNA was subjected to the first round of PCR with each set of primers. PCR was performed with TaKaRa Ex Taq for 35 cycles (consisting of denaturation for 1 min at 93 °C, annealing for 1 min at 55 °C and extension for 1 min at 74 °C), followed by an extension cycle at 74 °C for 8 min. The second round of PCR was carried out for 30 cycles consisting of the same protocol as those in the first round. The primers for the first and the second PCR rounds were as reported previously (Shan et al., 2002).
We used the standard numbering system in this report, the numbering of the bases commencing at the cleavage site for the restriction enzyme EcoRI in the preS2 region and the full length of 3215 bp being counted.
We used each set of sequencing primers for nucleotide sequences of HBV isolates shown previously (Shan et al., 2002). Direct sequencing of the PCR products was carried out by a fluorescence autosequencer (model 377; Perkin Elmer Applied Biosystems), using a BigDye Terminator Sequencing kit (Perkin Elmer Applied Biosystems) according to the manufacturer's instructions. Six overlapping segments were joined and phylogenetic analysis of the sequences of HBV clones was performed by the neighbour-joining method with the aid of CLUSTAL W (http://www.ddbj.nig.ac.jp/search/clustalw-j.html).
We compared the clones determined in our present study with eight reported HBV clones and confirmed their genotype to be B by phylogenetic analysis. The names of clones and the genotypes of their HBV sequences used in the analysis were as follows: GenBank AB014370 [GenBank] (genotype A), X97850 [GenBank] (genotype B), X75665 [GenBank] (genotype C), J02203 (genotype D), X75664 [GenBank] (genotype E), X75663 [GenBank] (genotype F), AF160501 [GenBank] (genotype G) and AY090457 [GenBank] (genotype H).
We used four representative clones from four subgenotypes of HBV/B, i.e. B1–B4, in addition to the present HBV/B clones from the Philippines for the study of the divergences in the entire sequences among the subgenotypes of HBV/B in Asian countries. The GenBank accession numbers of HBV sequences and countries from which they were derived were as follows: D00329 [GenBank] (Japan, B1); AF282917 [GenBank] (China, B2); AB033554 [GenBank] (Indonesia, B3); and AB031267 [GenBank] (Vietnam, B4).
We compared the precore and core sequences of our five clones from the Philippines and four previous isolates from subgenotypes B1–B4 with HBV/C and HBV/B1 by following the method of Sugauchi et al. (2002, 2003). The GenBank accession numbers and the countries from which they were derived are as follows: HBV/C, AB014378
[GenBank]
(Japan) and D23684
[GenBank]
(Japan); HBV/B1, AB073845
[GenBank]
(Japan) and AB073855
[GenBank]
(Japan).
Entire nucleotide sequences of five HBV/B isolates from the Philippines were determined. They were registered with DDBJ/GenBank under the accession numbers AB219426 [GenBank] , AB219427 [GenBank] , AB219428 [GenBank] , AB219429 [GenBank] and AB219430 [GenBank] .
Serotypes were determined from aa 122 and 160 in the HBs gene. GenBank AB219430 [GenBank] was found to be of serotype adw and AB219426 [GenBank] , AB219427 [GenBank] , AB219428 [GenBank] and AB2194294 were of serotype ayw.
We constructed a phylogenetic tree by using the entire nucleotide sequences determined from the five isolates, other HBV/B isolates retrieved from DDBJ/GenBank and additional representative genotypes (A, C, D, E, F, G and H). The HBV isolates are illustrated in Fig. 1, the HBV/B isolates detected worldwide being divided into five groups: subgenotypes B1, B2, B3, B4 and the Philippines group. We suggest the latter to be a new HBV/B subgenotype, B5. Among the present five isolates, four isolates belonged to subgenotype B5 and the other was subgenotype B3.
|
. The four isolates in subgenotype B5 showed 1·0–2·0 % divergence from each other. Among the sequences registered with GenBank, AB033554
[GenBank]
(subgenotype B3, serotype adw) from Indonesia showed the lowest divergences with the four isolates, 2·9–3·5 %. These four isolates showed divergences of 3·8–4·2 % with GenBank AB219430
[GenBank]
and, similarly, 4·4–4·8 % with Vietnam (B4), 4·7–5·1 % with China (B2) and 5·4–6·0 % with Japan (B1).
|
In addition, we constructed a phylogenetic tree by using the partial nucleotide sequences (369 bp in the HBs region) determined from 30 HBV/B isolates from the Philippines (Fig. 2). As for the four HBV/B subgenotypes, they were not as obvious in this tree as in that constructed from entire nucleotide sequences. To the contrary, the 17 isolates constructed an obvious subgroup with the serotype ayw, with one exception, which is characteristic for B5.
|
, a comparison of nucleotide similarities from positions 1814 to 2452 in the precore and core gene of the present five isolates from the Philippines and representative HBV/B isolates from the other four subgenotypes, B1–B4, with isolates from HBV/C and B1 is shown in Supplementary Table S1 in JGV Online. The divergences confirmed that HBV/B in the Philippines had recombined with HBV/C in the precore and core gene, like in B2, B3 and B4. In this study, we determined the entire nucleotide sequences of five HBV/B isolates from the Philippines, where data on HBV have been scant.
We showed that HBV/B isolates from all over the world, including the Philippines, can be divided into five subgroups in the phylogenetic tree based on entire nucleotide sequences, whose geographical distances and genetic distances are well-correlated. There were long genetic distances among the subgroups, i.e. subgenotypes. In general, subgenotypes vary by >4·0 % at the nucleotide level over the entire genome, as described by Norder et al. (2004) and Kramvis et al. (2005). In our study, the divergence of the entire-genome nucleotide sequences between GenBank AB219427
[GenBank]
(B5) and D00329
[GenBank]
(B1) was 6·0 %, that with AF282917
[GenBank]
(B2) was 5·1 %, that with AB033554
[GenBank]
(B3) was 3·5 % and that with AB031267
[GenBank]
(B4) was 4·7 %.
We suggest that the subgroup composed of four HBV/B isolates from the Philippines is a new subgenotype, B5, for the following three reasons. First, a significant bootstrap value was confirmed on the phylogenetic-tree analysis. Second, the divergences between B5 and the other four subgenotypes, B1, B2, B3 and B4, were nearly 4 %. Third, as for the serotypes, B3 was adw and B5 was ayw. We confirmed an additional 25 HBV clones in the Philippines to be genotype B from the sequence analysis of 369 bp (nt 278–646) in the HBs region. Phylogenetic-tree analysis of partial nucleotide sequences also showed the subgenotype B5. Seventeen clones among the 30 isolates, including the current four isolates, belonged to B5. Their serotypes were ayw with one exception (adw). This may be derived from just one point mutation in the HBsAg region. HBV infection is known to show clinical differences among genotypes. Therefore, these five HBV/B subgenotypes might show clinical differences, as previously reported for B1 (Bj) and B2 (Ba) (Orito et al., 2001).
This is the first report of the entire nucleotide sequences of HBV/B from the Philippines, where there have been scant data on HBV. It shows that they belong to a novel HBV/B subgenotype, B5. Further studies, including other genotypes and their clinical relevance, should be conducted.
|
REFERENCES |
|---|
|
TOPABSTRACTMAIN TEXTREFERENCES |
|---|
Kramvis, A., Kew, M. & François, G. (2005). Hepatitis B virus genotypes. Vaccine 23, 2409–2423.[CrossRef][Medline]
Lee, W. M. (1997). Hepatitis B virus infection. N Engl J Med 337, 1733–1745.
Lindh, M., Andersson, A. S. & Gusdal, A. (1997). Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus – large-scale analysis using a new genotyping method. J Infect Dis 175, 1285–1293.[Medline]
Lingao, A. L., Torres, N. T., Munoz, N., Lansang, M. A., West, S. K., Bosch, F. X. & Domingo, E. O. (1989). Mother to child transmission of hepatitis B virus in the Philippines. Infection 17, 275–279.[CrossRef][Medline]
Magnius, L. O. & Norder, H. (1995). Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 38, 24–34.[Medline]
Niitsuma, H., Ishii, M., Saito, Y., Miura, M., Kobayashi, K., Ohori, H. & Toyota, T. (1995). Prevalence of precore-defective mutant of hepatitis B virus in HBV carriers. J Med Virol 46, 397–402.[Medline]
Norder, H., Hammas, B., Löfdahl, S., Couroucé, A.-M. & Magnius, L. O. (1992). Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 73, 1201–1208.
Norder, H., Couroucé, A.-M., Coursaget, P., Echevarria, J. M., Lee, S.-D., Mushahwar, I. K., Robertson, B. H., Locarnini, S. & Magnius, L. O. (2004). Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47, 289–309.[CrossRef][Medline]
Okamoto, H., Imai, M., Tsuda, F., Tanaka, T., Miyakawa, Y. & Mayumi, M. (1987). Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 61, 3030–3034.
Okamoto, H., Tsuda, F., Sakugawa, H., Sastrosoewignjo, R. I., Imai, M., Miyakawa, Y. & Mayumi, M. (1988). Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69, 2575–2583.
Orito, E., Mizokami, M., Sakugawa, H., Michitaka, K., Ishikawa, K., Ichida, T., Okanoue, T., Yotsuyanagi, H. & Iino, S. (2001). A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Hepatology 33, 218–223.[CrossRef][Medline]
Shan, H., Niitsuma, H., Nagasaki, F., Cervantes, J. G., Ojima, T., Ueno, Y., Kobayashi, K., Ishii, M. & Shimosegawa, T. (2002). Analysis of the entire nucleotide sequence of hepatitis B virus: characteristics of HBeAg-positive asymptomatic carriers, HBeAb positive asymptomatic carriers and patients with liver cirrhosis. Hepatol Res 23, 251–264.[Medline]
Stuyver, L., De Gendt, S., Van Geyt, C., Zoulim, F., Fried, M., Schinazi, R. F. & Rossau, R. (2000). A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81, 67–74.
Sugauchi, F., Orito, E., Ichida, T. & 9 other authors (2002). Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol 76, 5985–5992.
Sugauchi, F., Orito, E., Ichida, T. & 10 other authors (2003). Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology 124, 925–932.[CrossRef][Medline]
Sunitha, K., Kim, Y.-O., Lee, J.-K. & 13 other authors (2000). Genoepidemiology and its relationship to clinical features in patients infected chronically with hepatitis B virus (HBV). Hepatol Res 17, 43–55.
Received 13 September 2005;
accepted 6 January 2006.
This article has been cited by other articles:
|
|
 |
|
  M. I. Lusida, V. E. Nugrahaputra, Soetjipto, R. Handajani, M. Nagano-Fujii, M. Sasayama, T. Utsumi, and H. Hotta Novel Subgenotypes of Hepatitis B Virus Genotypes C and D in Papua, Indonesia J. Clin. Microbiol., July 1, 2008; 46(7): 2160 - 2166. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
